Santos Gilberto Maia, Ismael Shámila, Morais Juliana, Araújo João R, Faria Ana, Calhau Conceição, Marques Cláudia
Nutrition and Metabolism, NOVA Medical School, Faculdade de Ciências Médicas, Universidade NOVA de Lisboa, 1169-056 Lisboa, Portugal.
CINTESIS-Center for Health Technology Services Research, NOVA Medical School, Faculdade de Ciências Médicas, Universidade NOVA de Lisboa, 1169-056 Lisboa, Portugal.
Microorganisms. 2022 Mar 30;10(4):746. doi: 10.3390/microorganisms10040746.
Intestinal alkaline phosphatase (IALP) has recently assumed a special relevance, being the subject of study in the prevention and treatment of certain diseases related to leaky gut. This brush border enzyme (ecto-enzyme) plays an important role in the maintenance of intestinal microbial homeostasis and intestinal barrier function through its ability to dephosphorylate lipopolysaccharide (LPS). This review addresses how IALP and intestinal barrier dysfunction may be implicated in the pathophysiology of specific diseases such as inflammatory bowel disease, necrotizing enterocolitis, and metabolic syndrome. The use of IALP as a possible biomarker to assess intestinal barrier function and strategies to modulate IALP activity are also discussed.
肠碱性磷酸酶(IALP)最近受到了特别关注,成为预防和治疗某些与肠漏相关疾病的研究对象。这种刷状缘酶(外切酶)通过其使脂多糖(LPS)去磷酸化的能力,在维持肠道微生物稳态和肠道屏障功能方面发挥着重要作用。本文综述了IALP和肠道屏障功能障碍如何可能与诸如炎症性肠病、坏死性小肠结肠炎和代谢综合征等特定疾病的病理生理学相关。还讨论了将IALP用作评估肠道屏障功能的可能生物标志物以及调节IALP活性的策略。